Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2011 | $54,000 | | enterprise zone |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2009 | $54,069 | | tax credit/rebate; property tax abatement |
NewLink Genetics Corporation | Lumos Pharma | Pennsylvania | state | 2016 | $54,105 | | tax credit/rebate |
Nupathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2010 | $54,157 | | tax credit/rebate |
United Therapeutics Corporation and Subs. | United Therapeutics | Maryland | state | 2017 | $54,182 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2012 | $54,345 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2015 | $54,370 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | North Carolina | state | 2016 | $54,466 | | tax credit/rebate |
Astellas Pharma Manufacturing, Inc. | Astellas Pharma | New York | local | 2007 | $54,956 | | tax credit/rebate; property tax abatement |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $55,000 | | tax credit/rebate |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2011 | $55,000 | | grant |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2015 | $55,013 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2011 | $55,480 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2021 | $55,509 | | tax credit/rebate |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2011 | $55,629 | | training reimbursement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2008 | $55,672 | | tax credit/rebate; property tax abatement |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2008 | $56,054 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2009 | $56,100 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Maryland | state | 2009 | $56,291 | | tax credit/rebate |
Johnson & Johnson | Johnson & Johnson | New York | local | 2005 | $56,350 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $56,648 | | tax credit/rebate; property tax abatement |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2015 | $56,783 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2020 | $56,926 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $56,975 | | tax credit/rebate |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2005 | $57,000 | | enterprise zone |
PFIZER INC | Pfizer | Tennessee | local | 2011 | $57,012 | | property tax abatement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2018 | $57,440 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2013 | $57,596 | | tax credit/rebate |
NewLink Genetics Corporation | Lumos Pharma | Pennsylvania | state | 2015 | $57,669 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2022 | $57,678 | | tax credit/rebate |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2008 | $57,716 | | training reimbursement |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $57,885 | | tax credit/rebate |
Regeneron Garage Addition 25 Discovery Dr. | Regeneron Pharmaceuticals | New York | local | 2019 | $58,198 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2014 | $58,245 | | property tax abatement |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2017 | $58,747 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. (FKA Emergent InnunoSolutions, Inc.) | Emergent BioSolutions | Maryland | state | 2007 | $58,921 | | tax credit/rebate |
ST. JUDE MEDICAL | Abbott Laboratories | South Carolina | state | 2009 | $59,305 | | training reimbursement |
MILLIPORE CORPORATION | Merck KGaA (EMD) | California | state | 2011 | $59,646 | | training reimbursement |
VISX INCORPORATED | Abbott Laboratories | California | state | 2006 | $59,748 | | training reimbursement |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2012 | $59,756 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2014 | $59,756 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $59,897 | | tax credit/rebate |
Chiron Corporation | Novartis | Pennsylvania | state | | $60,000 | | tax credit/rebate |
Auxilium Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | | $60,000 | | grant |
Pfizer Inc. | Pfizer | Maryland | state | 2005 | $60,097 | | tax credit/rebate |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2008 | $60,135 | | tax credit/rebate; property tax abatement |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $60,285 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2007 | $60,433 | | tax credit/rebate; property tax abatement |
Icagen, Inc. | Pfizer | North Carolina | state | 2015 | $60,444 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2012 | $60,651 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2014 | $60,651 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $60,750 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $60,963 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2011 | $60,998 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2010 | $61,206 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2015 | $61,459 | | tax credit/rebate |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $61,743 | | tax credit/rebate; property tax abatement |
Amgen Inc. | Amgen | Maryland | state | 2005 | $61,793 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE | Johnson & Johnson | Tennessee | local | 2013 | $61,809 | | property tax abatement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $62,249 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2019 | $62,460 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2010 | $62,485 | | property tax abatement |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2011 | $62,613 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2013 | $62,739 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Eli Lilly | North Carolina | state | 2010 | $62,965 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2009 | $62,980 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2014 | $63,126 | | enterprise zone |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $63,148 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2016 | $63,252 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $63,375 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2007 | $63,676 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2008 | $64,386 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $64,525 | | tax credit/rebate |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2013 | $64,733 | | property tax abatement |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $64,881 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $65,000 | | grant |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2013 | $65,000 | | grant |
Otsuka America Inc. | Otsuka Pharmaceutical | Maryland | state | 2010 | $65,321 | | tax credit/rebate |
Otsuka America, Inc. c/o Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2009 | $65,411 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2020 | $65,492 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $65,595 | | tax credit/rebate |
Abbott Laboratories Retrain | Abbott Laboratories | Virginia | state | 2017 | $65,639 | | training reimbursement |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $65,650 | | tax credit/rebate |
Liquent, Inc. | Parexel International | Pennsylvania | state | 2017 | $65,812 | | tax credit/rebate |
Codman and Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $66,093 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | Pfizer | North Carolina | state | 2016 | $66,776 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2009 | $66,838 | | tax credit/rebate |
Auxilium Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $66,990 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 1999 | $67,000 | | grant |
PFIZER INC | Pfizer | Tennessee | local | 2008 | $67,264 | | property tax abatement |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2016 | $67,627 | | enterprise zone |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $68,023 | | tax credit/rebate |
Genentech USA Inc | Roche | California | state | 2021 | $68,185 | | training reimbursement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2004 | $68,264 | | tax credit/rebate; property tax abatement |
OMEROS CORP | Omeros Corp. | Washington | state | 2006 | $68,653 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2018 | $68,671 | | tax credit/rebate |
Hospira, Inc. | Pfizer | Kansas | state | 2006 | $68,770 | | training reimbursement |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2010 | $68,808 | | tax credit/rebate |
PAREXEL International Corp. | Parexel International | Pennsylvania | state | 2017 | $69,000 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2009 | $69,750 | | property tax abatement |
CSL Behring, LLC. | CSL Limited | Pennsylvania | state | 2011 | $70,263 | | tax credit/rebate |